Paper # 1017
Oral Human Papillomavirus Infection among HIV-infected Men Who Have Sex with Men
Gypsyamber D’Souza*1, D Beachler1, L Jacobson1, J Margolick1, and M Gillison2
1Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US and 2Ohio State Univ, Columbus, US
Background: Human papillomavirus (HPV) causes a
subset of oropharyngeal cancers but the prevalence and risk factors for oral
HPV infection are not well understood. Initial studies suggest HIV-infected
individuals have an increased incidence of HPV-related cancers including
oropharyngeal cancer. More than 90% of HPV-associated oropharyngeal cancer is
caused by a single HPV type, HPV16.
Methods: Oral exfoliated cells were collected using
a swish and gargle with 10ml of Scope mouthwash in 149 HIV-infected and
HIV-uninfected men who have sex with men (MSM) in the Baltimore center of the
MACS. We hypothesized that MSM are high risk because of a high number of oral
sexual partners. Samples were tested for 37 types of HPV DNA using PGMY09/11
consensus primers and line blot hybridization. Logistic regression was used to
explore risk factors for infection.
Results: Prevalent oral HPV infection was common
among HIV-infected (39%) and HIV-uninfected MSM (28%). HPV16 was the most
common HPV type detected and was found in 13% of MSM overall (8.2% of
HIV-infected and 16% of HIV-uninfected MSM). Other oncogenic oral HPV
infections detected included HPV66, 68, 83 (2.0% prevalence each), 45, 53, 58,
59, 73 (1.3% each). In this group of MSM, 40% reported multiple oral sex partners
in the past 6 months. Oral HPV prevalence was non-significantly higher among
those with 2 or more than those with 0 to 1 recent oral sexual partners (39% vs
30%, P =0.29). The majority of HIV-infected participants were
currently on HAART (75%), had CD4 cell count>500 (65%) and HIV viral load
<500 copies/mL (89%). Oral HPV prevalence was comparable among current and
never HAART users (41% vs 40%) and was not associated with current CD4, or HIV
viral load. Among HIV-infected MSM oral HPV prevalence was associated with
younger age (66% prevalence in <45 year olds vs 20% in those over 65 years,
p-trend = 0.035), current marijuana use (64% vs 34%, P =0.07) and
not drinking alcohol (59% among never drinkers vs 21% among weekly/daily
drinkers, P =0.07). In multivariate analysis HIV-positive current
marijuana users were 10-times more likely (P =0.05) and current
alcohol users were 10x less likely (P =0.02) to have prevalent oral
HPV infection.
Conclusions: Oral HPV16 prevalence is alarmingly
high among MSM suggesting they may be at increased risk for HPV-associated
oropharyngeal cancers. Oral HPV prevalence was similar among HAART users and
non-users suggesting HAART may not improve oral HPV clearance.
|